Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-12-18
2009-10-06
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S180000
Reexamination Certificate
active
07598246
ABSTRACT:
The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases and diseases of the soft tissues surrounding bones.
REFERENCES:
patent: 4621077 (1986-11-01), Rosini
patent: 5130304 (1992-07-01), Binderup
patent: 5358941 (1994-10-01), Bechard
patent: 5428181 (1995-06-01), Sugioka et al.
patent: 5488041 (1996-01-01), Barbier
patent: 5580571 (1996-12-01), Hostetler
patent: 5721219 (1998-02-01), Ingall
patent: 5760013 (1998-06-01), Hwu et al.
patent: 5900410 (1999-05-01), Hartmann
patent: 6121253 (2000-09-01), Han et al.
patent: 6140518 (2000-10-01), Gallagher et al.
patent: 6605603 (2003-08-01), Roldan et al.
patent: 6750340 (2004-06-01), Padioukova et al.
patent: WO 88/00829 (1988-02-01), None
patent: WO 91/10646 (1991-07-01), None
patent: WO 95/35704 (1998-08-01), None
Gough, GR et al, Three new adenosine triphosphate analogs. Synthesis and effects on isolated gut, CA 80: 10270 (1974).
Gough et al., J. Me. Chem. (1973) vol. 16(10), pp. 1188-1190.
Buxton et al., Ciprofloxacin conjugated to bisphosphonate: Characterization of bone affinity in vitro,Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, 1998, vol. 38, p. 29, XP008043693.
Murud et al, Influence of pretreatment with 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APB) on organ uptake of 211At and 1251-labeled amidobisphosphonates in mice,Nuclear Medicine and Biology1999, vol. 26, No. 7, pp. 791-794, XP002319673.
Shtil et al., Novel bisphosphonate -based compounds for circumventing drug resistance in the bone-targeting human tumor cells,Proceedings of the American Association for Cancer Research Annual Meeting, San Francisco, California, 2000, No. 41, p. 398, XP002319674.
Buxton et al., Novel local drug delivery of antibiotic-bisphosphonate: binding and antibacterial effects,FASEB J.2001, vol. 15, No. 4, p. A587, XP008043697.
Fujisaki et al., Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug,Proceedings of the International Symposium f Controlled Release of Bioactive Materials22nd, 1995, abstract, figure 1, XP008043630.
Fleisch (Feb. 1998) Endocrine Reviews 19(1): 80-100, Biophosphonates: Mechanisms of Action.
Hosain et al. (Jan. 1996) The Journal of Nuclear Medicine 37(1):105-107, Targeted delivery of antineoplastic agent to bone: biostribution studies of technetium-99m-labeled gembisphosphonate conjugate of methotrexate.
Klein et al. (1998) Journal of Cellular Biochemistry 68:86-194, Structurally Different Biophosphonates Exert Opposing Effects of Alkaline Phosphatase and Mineralization in Marrow Osteoprogenitors.
Reinholtz et al. (Feb. 2002) Breast Cancer Research and Treatment, 71(3):257-268, Distinct mechanisms of biophosphonate action between osteoblasts and breast cancer cells: identity of a potent new biophosphonate analogue.
Rogers et al. (1995) Molecular Pharmacology 47:398-402, Structure-Activity Relationships of New Heterocycle-Containing Biophosphonates as Inhibitors of Bone Resorption and as Inhibitors of Growth ofDictyostelium discoideumAmoebae.
Hershey and Monro (1966) “A Competitive Inhibitor of the GTP Reaction in Protein Synthesis” J. Mol. Biol. 18:68-76.
Padyukova et al. (1999) “Synthesis and Properties of Novel NTP Derivatives” Nucleosides & Nucleotides 18(4&5):1013-1014.
Dixon H.B.F.
Karpeisky Marat
Karpeisky, legal representative Alexander
Mikhailov Sergey
Padioukova Nelly
MBC Pharma, Inc.
Solola Taofiq A
Swanson & Bratschun L.L.C.
LandOfFree
Bisphosphonate conjugates and methods of making and using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisphosphonate conjugates and methods of making and using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisphosphonate conjugates and methods of making and using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092897